Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 46 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/08/17
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 10/14/11
End: 02/17/16
Due: 02/17/17
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/18/23
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 05/09/06
End: 03/12/08
Due: 03/12/09
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/27/21
End: 03/11/22
Due: 03/11/23
Phase: N/A
Priority: Normal
Start: 10/11/19
End: 11/29/24
Due: 11/29/25
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 01/04/13
Due: 01/04/14
Phase: N/A
Priority: Normal
Start: 12/08/08
End: 12/14/09
Due: 12/14/10
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 12/31/11
Due: 12/31/12
Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/13/20
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 11/13/18
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 02/02/11
End: 10/09/12
Due: 10/09/13
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 09/07/06
End: 05/09/08
Due: 05/09/09
Phase: N/A
Priority: Normal
Start: 01/24/20
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 05/18/22
Due: 05/18/23
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 03/23/07
End: 02/19/08
Due: 02/19/09
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 08/20/24
Due: 08/20/25